Carlsbad
(760) 431-2273
Murrieta
(951) 600-9803
Ontario
(909) 947-3600
OPEN 24
HOURS
Nativis Voyager: New Groundbreaking Cancer Treatment
February 20, 2013


Greg Ogilvie, founder of the Angel Care Cancer Center at California Veterinary Specialists, has spent his life searching for new and improved cancer treatments for animals and their families. An award-winning, diverse and highly esteemed oncologist and veterinary researcher, Dr. Ogilvie works with a dedicated and highly qualified team of oncologists, oncology nurses and technicians testing the safety and efficacy of groundbreaking cancer treatments on dogs.

 

Dr. Ogilvie is directing a ground breaking canine clinical trial using a new and revolutionary non-invasive medical device called Voyager. "Voyager is just beginning its voyage as we are beginning the process of identifying the cancers its most effective to treat. It seems to have a broad spectrum of efficacy while being quite safe."

 

The Voyager results are remarkable. Rapid and durable tumor response has been seen in many patients, resulting in partial and complete remissions. After one week of treatment, Voyager safely eliminated 90% of one patient's malignant mass tumor.

 

The world class veterinary oncology teams at CVS Angel Care are inviting families to enroll their beloved canine cancer patients in this clinical trials with the firm believe that Voyager therapy can help, without hurting, and that the results of this clinical trial can greatly benefit canine cancer patients and eventually people who have similar cancers. "Our whole passion here at CVS Angel Care is being able to identify that which can bring help, compassion and hope to animals with cancer not just for our own hospital but for the world as a whole."

 

"When given an opportunity to actually have something that can help their pet, it's very empowering for them to know that they're going to have the opportunity to help their animal with cancer. Being a part of something bigger, being a part of an amazing discovery that will help literally thousands of animals and potentially people with cancer is something that they become very excited about."

 

Your dog may be eligible to enter this study if he or she has a measurable tumor, is in good health otherwise, and if you are willing to visit one of our three Angel Care Cancer Centers for weekly evaluations and assessments. Our centers are located in Murrieta, Carlsbad and Ontario California. For more information on how your dog can enter the Voyager Cancer Treatment Trial:

 

Call: (760) 431-2273
Email: cvscarlsbad@calvetspec.com



RELATED ARTICLES
Pedal the Cause: A World Without Cancer Fundraiser
Aug 12, 2014
The word cancer is as dark and empty as the disease it defines. A diagnosis of cancer often brings with it feelings of overwhelming fear, a spiraling sense of loss of control, and most devastating of all, the loss of hope. This occurs regardless of whether the patient is a human family member or a precious pet. I know, because I am a veterinary oncologist at California Veterinary Specialists Angel Care Cancer Center and am given the honor of doing everything I can to defeat cancer in my animal patients with compassionate care. Like my fellow...
Dr. Ogilvie Featured on KUSI-TV
Jun 12, 2013
In case you missed it, check out last week’s KUSI-TV live segment with Dr. Ogilvie as he discusses cancer treatment for animals.
Genelux Corporation Announces Ground-Breaking Clinical Study Evaluating Oncolytic Vaccinia Virus in Canine Cancer Patients
May 31, 2012
SAN DIEGO, May 31,2012 -- Genelux Corporation, a privately-held clinical-stage biopharmaceutical company focused on development and commercialization of best–in-class vaccinia virus based oncolytic viral therapies and companion diagnostics for human cancer patients, today announced the start of a ground-breaking clinical study involving the oncolytic Vaccinia virus V-VET1 in canine cancer patients with various measurable malignancies. Although oncolytic viruses are being more extensively evaluated in humans, this study is the first of its kind
San Diego K9 Cancer Walk
Feb 13, 2014
Come join us on Saturday, February 22, and support the San Diego K9 Cancer Walk Benefiting Morris Animal Foundation to help find a cure. California Veterinary Specialists will be there in full support of the Morris Foundation and will have a team walking as well. Our team name is Angel Care for the Cure and our Team Capitan is Leah Larscheidt. Please help support our team by joining us for the walk, donating to our team or just coming out to cheer us on. We hope to see you there!
CHOP/Monoclonal Antibody Lymphoma Study
Jul 02, 2012
Inclusion Criteria: Clinically healthy dogs with stage III/IVa cyto- or histologically confirmed intermediate or large cell B cell lymphoma and acceptable recent chest radiographs and blood work. Study will cover costs of flow cytometry, an abbreviated CHOP therapy +/- monoclonal antibody treatment plus weekly in-hospital rechecks and restagings at CVS.